Related Experiment Videos
Bone marrow-derived stem cells initiate pancreatic regeneration
David Hess1, Li Li, Matthew Martin
1Robarts Research Institute, Stem Cell Biology and Regenerative Medicine, 100 Perth Drive, London, Ontario N6A 5K8, Canada.
Nature Biotechnology
|June 24, 2003
Summary
Transplanting adult bone marrow cells into diabetic mice reduced hyperglycemia. These cells stimulated the mice
Area of Science:
- Stem cell biology
- Endocrinology
- Regenerative medicine
Background:
- Diabetes mellitus is characterized by pancreatic beta-cell dysfunction or loss.
- Current treatments for diabetes are often insufficient for complete disease management.
- Exploring novel therapeutic strategies for pancreatic regeneration is crucial.
Purpose of the Study:
- To investigate the therapeutic potential of adult bone marrow-derived cells (BMDCs) in a mouse model of diabetes.
- To determine the mechanism by which BMDCs might restore pancreatic function and reduce hyperglycemia.
Main Methods:
- Induction of pancreatic damage and hyperglycemia in mice using streptozotocin.
- Transplantation of adult bone marrow-derived cells expressing c-kit into these mice.
- Analysis of pancreatic tissue, including cell proliferation, insulin production, and donor cell localization.
Main Results:
- Transplanted BMDCs significantly reduced hyperglycemia in mice with pancreatic damage.
- A low frequency of donor insulin-positive cells was observed, and they did not correlate with the onset of glucose reduction.
- Transplanted cells localized to pancreatic ductal and islet structures, promoting recipient cell proliferation and endogenous insulin production.
Conclusions:
- Adult bone marrow-derived cells can initiate endogenous pancreatic tissue regeneration.
- This regenerative capacity offers a novel mechanism for restoring pancreatic function in diabetes.
- BMDC transplantation represents a promising therapeutic avenue for diabetes treatment.